Christophe Pannecouque Selected Research

Christophe Pannecouque Research Topics

Disease

15	Acquired Immunodeficiency Syndrome (AIDS) 04/2024 - 04/2006
13	Infections 04/2021 - 07/2002
8	HIV Infections (HIV Infection) 01/2018 - 09/2005
5	Human Influenza (Influenza) 03/2020 - 12/2003
4	Neoplasms (Cancer) 10/2016 - 01/2002
3	Virus Diseases (Viral Diseases) 04/2021 - 08/2012
2	autosomal dominant Spastic paraplegia 6 08/2022 - 03/2021
2	Dengue (Dengue Fever) 01/2021 - 01/2020
2	Zika Virus Infection 01/2021 - 01/2020
1	Liver Diseases (Liver Disease) 04/2021
1	Drug-Related Side Effects and Adverse Reactions 02/2020
1	Prostatic Neoplasms (Prostate Cancer) 01/2018
1	Extensively Drug-Resistant Tuberculosis 01/2016
1	AIDS-Related Lymphoma (Lymphoma, AIDS Related) 09/2015
1	Hepatocellular Carcinoma (Hepatoma) 01/2013
1	Carbuncle 06/2010
1	Noncommunicable Diseases 06/2010
1	Furunculosis (Boils) 06/2010
1	Wounds and Injuries (Trauma) 06/2010
1	Vaccinia 06/2009
1	Vesicular Stomatitis 06/2009
1	Melanoma (Melanoma, Malignant) 05/2006
1	Leukemia 05/2006
1	Synucleinopathies 03/2006
1	Necrosis 11/2005

Drug/Important Bio-Agent (IBA)

13	Antiviral Agents (Antivirals)IBA 04/2021 - 03/2002
11	NucleosidesIBA 03/2024 - 01/2002
7	Reverse Transcriptase InhibitorsIBA 03/2024 - 04/2006
5	Human immunodeficiency virus 1 reverse transcriptaseIBA 04/2023 - 09/2005
2	pyrimidineIBA 03/2020 - 06/2015
2	Ribavirin (Virazole)FDA LinkGeneric 10/2015 - 06/2012
2	Rimantadine FDA LinkGeneric 10/2015 - 06/2012
2	Amantadine (Aman)FDA LinkGeneric 10/2015 - 06/2012
1	Proteins (Proteins, Gene)FDA Link 04/2024
1	CarbonIBA 03/2021
1	Indole AlkaloidsIBA 01/2021
1	3- (5- nitrofuryl)- 7- (5- nitrofurfurylidene)- 3,3a,4,5,6,7- hexahydro- 2H- indazoleIBA 05/2020
1	Ribonuclease H (RNase H)IBA 03/2020
1	Glycoproteins (Glycoprotein)IBA 01/2020
1	Tryptophan (L-Tryptophan)FDA Link 01/2020
1	Carboxylic AcidsIBA 01/2020
1	AndrogensIBA 01/2018
1	compound 18IBA 10/2016
1	AGRO 100IBA 04/2016
1	1,3,4-thiadiazoleIBA 01/2016
1	UracilIBA 01/2016
1	ThioureaIBA 01/2016
1	Amino Acids FDA Link 12/2015
1	BenzenesulfonamidesIBA 12/2015
1	PurinesIBA 10/2015
1	piperidineIBA 10/2015
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 06/2015
1	BRACO-19IBA 12/2014
1	Single-Domain AntibodiesIBA 12/2014
1	2- methyl- 3- phenyl- 2H- (1,2,4)thiadiazol- 5- ylideneamineIBA 11/2012
1	HIV ProteaseIBA 09/2012
1	Human immunodeficiency virus 1 p16 proteaseIBA 09/2012
1	oseltamivir carboxylateIBA 06/2012
1	ThiazolesIBA 06/2012
1	acetamideIBA 06/2012
1	Ointments (Pastes)IBA 06/2010
1	PowdersIBA 06/2010
1	CarbohydratesIBA 11/2009
1	phthalocyanineIBA 11/2009
1	Alcian BlueIBA 11/2009
1	Acyclovir (Aciclovir)FDA LinkGeneric 06/2009
1	DipeptidesIBA 06/2009
1	EstersIBA 06/2009
1	ProdrugsIBA 06/2009
1	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 02/2008
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 02/2008
1	HIV Reverse TranscriptaseIBA 10/2007
1	QuinolonesIBA 04/2007
1	ZincIBA 10/2006
1	Cytostatic AgentsIBA 05/2006
1	IonsIBA 03/2006
1	alpha-SynucleinIBA 03/2006
1	MetalsIBA 03/2006
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2005
1	phorbolIBA 11/2005
1	Green Fluorescent ProteinsIBA 05/2005
1	RNA (Ribonucleic Acid)IBA 05/2005
1	L 708906IBA 10/2002
1	Complementary DNA (cDNA)IBA 07/2002
1	EnzymesIBA 07/2002
1	HIV IntegraseIBA 07/2002
1	ThiosemicarbazonesIBA 03/2002

Therapy/Procedure

13	Therapeutics 01/2023 - 07/2002
4	Highly Active Antiretroviral Therapy (HAART) 01/2018 - 10/2007
1	Oral Administration 09/2015